XTL Biopharmaceuticals Ltd (XTLB)
2.422
+0.02
(+0.92%)
USD |
NASDAQ |
Apr 26, 16:00
XTL Biopharmaceuticals Price to Book Value: 5.277 for April 26, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| April 26, 2024 | 5.277 |
| April 25, 2024 | 5.229 |
| April 24, 2024 | 5.578 |
| April 23, 2024 | 5.643 |
| April 22, 2024 | 5.774 |
| April 19, 2024 | 5.316 |
| April 18, 2024 | 5.316 |
| April 17, 2024 | 5.382 |
| April 16, 2024 | 5.665 |
| April 15, 2024 | 5.839 |
| April 12, 2024 | 5.665 |
| April 11, 2024 | 6.013 |
| April 10, 2024 | 6.057 |
| April 09, 2024 | 6.928 |
| April 08, 2024 | 6.863 |
| April 05, 2024 | 7.103 |
| April 04, 2024 | 6.776 |
| April 03, 2024 | 7.255 |
| April 02, 2024 | 6.144 |
| April 01, 2024 | 6.558 |
| March 28, 2024 | 6.122 |
| March 27, 2024 | 5.883 |
| March 26, 2024 | 6.689 |
| March 25, 2024 | 6.122 |
| March 22, 2024 | 5.708 |
| Date | Value |
|---|---|
| March 21, 2024 | 5.273 |
| March 20, 2024 | 5.186 |
| March 19, 2024 | 2.266 |
| March 18, 2024 | 2.525 |
| March 15, 2024 | 1.917 |
| March 14, 2024 | 1.926 |
| March 13, 2024 | 2.070 |
| March 12, 2024 | 2.092 |
| March 11, 2024 | 2.092 |
| March 08, 2024 | 2.004 |
| March 07, 2024 | 1.852 |
| March 06, 2024 | 1.982 |
| March 05, 2024 | 1.982 |
| March 04, 2024 | 1.961 |
| March 01, 2024 | 1.961 |
| February 29, 2024 | 1.905 |
| February 28, 2024 | 1.751 |
| February 27, 2024 | 1.873 |
| February 26, 2024 | 1.873 |
| February 23, 2024 | 1.842 |
| February 22, 2024 | 1.743 |
| February 21, 2024 | 1.809 |
| February 20, 2024 | 1.896 |
| February 16, 2024 | 1.852 |
| February 15, 2024 | 1.928 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
0.6741
Minimum
Apr 06 2020
8.368
Maximum
Sep 02 2021
2.439
Average
1.853
Median
Jan 09 2023
Price to Book Value Benchmarks
| Compugen Ltd | 2.622 |
| Pluri Inc | 6.365 |
| BioLine Rx Ltd | 3.697 |
| Can Fite Biofarma Ltd | 1.583 |
| BiomX Inc | 6.273 |
Price to Book Value Related Metrics
| Price | 2.422 |
| Earnings Yield | -16.52% |
| Market Cap | 13.20M |